The mission of the Doctor of Medical Science Program is to prepare doctoral-level-trained PAs to provide compassionate care, leadership, advocacy and education to their communities and the profession, with an emphasis on underserved populations and health care professional shortage areas.

A partial list of our notable accomplishments and innovations. SIU School of Medicine was the first institution to incorporate problem-based learning and standardized patients into its medical school curriculum. We were the first medical school in the U.S. to require a clinical competency examination before graduation. The exam is now a model for physician licensure throughout the country. The Professional Development Laboratory allows evaluation of students in standardized and real patient encounters in a precise replica of an exam room. It was the first such facility in the nation, providing

In 1968, the Illinois Board of Higher Education sparked the creation of something necessary and bold: Its members recommended that Southern Illinois University establish a medical school. Placing the clinical education programs of the new school in Springfield and basic science programs in Carbondale would make use of the educational resources already available on the downstate campus and the established health care networks in the State Capital. Primary care for downstate Illinois Under the direction of the founding dean, Dr. Richard H. Moy, SIU School of Medicine was established in 1970 with

SIU Medicine will continue COVID-19 testing for the Springfield community in February. On Mondays, Tuesdays and Thursdays, the testing operation will be hosted by Abundant Faith Christian Center located at 2525 Taylor Ave. Mondays: 9 – 11 a.m. and 1 – 4 p.m. Tuesdays: 9 – 11 a.m. and 1 – 4 p.m. Thursdays: 9 – 11 a.m. and 1 – 4 p.m. Fridays: 1 – 4 p.m. (at Abundant Faith Christian Center, 301 West Reynolds Campus) Additional testing is conducted on Fridays, hosted by other area congregations. February 5, 9 a.m. - noon at Monroe Street Christian Church, 1229 E. Monroe St. February 12, 9 a.m. -

2021 Memorial Medical Center Foundation Grant Application

Riluzole is an FDA-approved drug, currently used to treat amyotrophic lateral sclerosis (ALS; Lou Gehrig's disease) and is currently in a Phase II clinical trial for the treatment of mild Alzheimer’s disease (AD) (Clinical Trial #NCT01703117). The exact reason behind riluzole’s potential benefits on cognition in AD patients is unknown. One potential way may be through altering glutamate signaling in the brain, a neurotransmitter essential for learning and memory. A team of researchers at the Center for Alzheimer’s Disease and Related Disorders at SIU Medicine lead by Kevin N. Hascup, PhD, and

SIU Medicine is recruiting patients with early-stage Parkinson’s disease to study a new drug that could become a potential treatment for the debilitating condition. Parkinson's disease (PD) is a nervous system disorder that affects movement, causing slowness, stiffness, tremors and walking and balance problems. Over time, patients diagnosed with PD experience a worsening of their symptoms. In the early stages of Parkinson’s disease, symptoms may be mild and the diagnosis can be easily missed. The symptoms include: Slowed movement, also known as bradykinesia (difficulties getting out of a chair

Southern Illinois University School of Medicine Department of Population Science and Policy (PSP) works to understand the health challenges of people in central and southern Illinois and provides innovative, sustainable solutions to improve health in their communities. PSP is invited into communities by local stakeholders and changemakers to identify and pull together resources; provide workshops, focus groups and community training; collect and organize data; conduct community needs assessments; identify and implement solutions to improve health; and inform and improve local, state and

All SIU Medicine COVID-19 testing sites are closed December 23 – January 3 for the holidays. Testing resumes on January 4, 2021. SIU Medicine will continue COVID-19 testing for the Springfield community in January. On Mondays, Tuesdays and Thursdays, the testing operation will be hosted by the Abundant Faith Christian Center located at 2525 Taylor Ave. Mondays: 9 – 11 a.m. and 1 – 4 p.m. Tuesdays: 9 – 11 a.m. and 1 – 4 p.m. Thursdays: 9 – 11 a.m. and 1 – 4 p.m. Fridays: 1 – 4 p.m. (at Abundant Faith Christian Center, 301 West Reynolds Campus) Additional testing is conducted on Fridays, hosted